AVBP
Arrivent Biopharma Inc
NASDAQ · Biotechnology
$21.86
+0.51 (+2.39%)
Open$21.86
Previous Close$21.35
Day High$22.36
Day Low$21.42
52W High$29.57
52W Low$15.47
Volume—
Avg Volume588.2K
Market Cap902.41M
P/E Ratio—
EPS$-4.24
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+17.1% upside
Current
$21.86
$21.86
Target
$25.60
$25.60
$15.99
$25.60 avg
$32.44
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 217.05M | 207.22M | 172.47M |
| Net Income | -33,899,494 | -32,015,874 | -32,580,881 |
| Profit Margin | -15.6% | -15.5% | -18.9% |
| EBITDA | -52,835,285 | -48,435,254 | -38,009,184 |
| Free Cash Flow | -36,657,940 | -37,197,569 | -30,385,570 |
| Rev Growth | +1.9% | +19.8% | +13.5% |
| Debt/Equity | 0.28 | 0.20 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |